Dianthus Therapeutics (DNTH) Misses Q1 EPS by 54c

Dianthus Therapeutics (NASDAQ: DNTH) reported Q1 EPS of ($0.54). Revenue for the quarter came in at $870 thousand.

For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.

You May Also Be Interested In

• Cerebras CEO says investors misunderstood margin guidance
• MillerKnoll, Inc. (MLKN) Tops Q4 EPS by 4c
• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’